Politics / Law

New food and GMO guidelines

10.06.2011

Parma – The EU’s food watchdog EFSA published two biotech-relevant guidelines in May – one on gut and immune system related health claims, and one on GMO food and feed safety assessments.
The update on risk assessments of food and feed made from GM plants covers the latest scientific developments in allergenicity and toxicology testing, design of field trials, animal feeding studies and analysis of stacked events such as multiple insect resistance and herbicide tolerance.
The long-awaited guidance document on gut and immune system-related health claims gives more information on appropriate study groups (for example people with irritable bowel syndrome or functional constipation). It also looks at which parameters or clinical outcomes for health claims covering bowel function, allergy-reduction, and maintenance of normal immune function may be accepted by the authority’s NDA panel.
While industry representatives complain that the new guidance isn’t significantly different than the EFSA’s draft document, Nutri­alpha Europe said it was the first time the agency had provided clear recommendations regarding the choice of target populations for human studies and on R&D strategies to substantiate health claims.
Prior to the publication, a group of pro­biotics experts led by Ger Rijkers (Univ. Utrecht) had criticised EFSA’s reluctance to publish a list of definitive markers and study populations for substantiation of health claims. EFSA says it will continue to evaluate claims on a case-by-case basis.

Politics / Law

23.03.2012

Brussels/Strasbourg – Health claims are set to be drastically limited in the EU. On Wednesday 21 March the Environment Committee of the European Parliament confirmed a proposal of the European Commission to prohibit 1,600 health...

Politics / Law

15.03.2012

Parma/Stockholm – Foodborne bacteria such as Salmonella and Campylobacter are becoming more and more resistant to antimicrobial drugs, according to a joint report published by the European food watchdog EFSA and the European...

BioFunding

09.03.2012

In mid-February, scientists and entrepreneurs from nine EU countries met at the Center for Genomic Regulation (CRG) in Barcelona to launch the 4DCellFate project. Positioned within the FP7 Programme, the consortium will receive...

BioFunding

09.03.2012

Brussels – The EU’s Innovative Medicines Initiative (IMI) will establish the European Lead Factory, an EU-wide public-private partnership aiming to facilitate drug discovery efforts. The Lead Factory will comprise a...

Editorial

07.03.2012

T    he societal and economic challenges facing Europe and the world are complex and interconnected. The Bioeconomy Strategy and Action Plan “Innovating for Sustainable Growth: a Bioeconomy for Europe”, which was adopted by the...

Tech Review

07.03.2012

Intellectual Property (IP) is without question one of the most vital aspects of any bio­tech venture, a key and undisputed factor for success. However, most bio­tech companies are still incapable of unlocking the value of their...

Clinical Trial

07.03.2012

Schlieren – Swiss Cytos Biotechnology Ltd. has been authorised to restructure a convertible bond by Canton of Zurich authorities. The company does not have enough cash to pay it back. Negotiations with bond holders failed in a...

Clinical Trial

06.03.2012

Munich – German 4SC AG jumped 39% to €2.05/share after oncology drug candidate resminostat met the primary endpoint of at least a 20% progression-free survival rate in a Phase II trial to treat patients with hepatocellular...

Editorial

06.03.2012

The start of 2012 witnessed the tides turning in favour of small and mid-cap names in the European Life Sciences sector. Major global biotechnology indices like the NBI, BTK, and BIOTK are up over 15% year to date. The pace of...

Displaying results 1 to 10 out of 1982

1-10 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive/article/new-food-and-gmo-guidelines.html

Product of the week

Products

Events

All Events

Current issue

All issues